Vaidya Sane Ayurved Laboratories Ltd.
•₹ 169.952.41%
2026-08-21
PROS
- Company is almost debt free
- Company comfortably covers its interest (44.8x coverage)
- Company generates healthy free cash flow
CONS
- Receivables are growing faster than sales - a possible quality concern
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | APOLLOHOSP | 8799.00 | 60.55 | 126516.12 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| 2. | MANIPALHOS | 744.55 | 109.75 | 97936.41 | 0.00 | — | — | — | — | 13.93 | — |
| 3. | MAXHEALTH | 996.45 | 66.57 | 96982.14 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| 4. | ASTERDM | 800.70 | 219.01 | 69794.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| 5. | FORTIS | 910.80 | 65.62 | 68761.59 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| 6. | MEDANTA | 1419.05 | 68.60 | 38154.25 | 0.04 | 157.25 | -1.09 | 1304.05 | 26.50 | 20.50 | 21.99 |
| 7. | NH | 1782.70 | 44.64 | 36431.40 | 0.25 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| 8. | KIMS | 788.60 | 162.12 | 33121.71 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| 9. | LALPATHLAB | 1886.80 | 58.44 | 31669.72 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| 10. | AGARWALEYE | 499.70 | 106.77 | 15841.80 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 14.32 | 27.75 |
| 11. | VIJAYA | 1489.70 | 81.84 | 15343.57 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.27 | 42.66 |
| 12. | MADHAVBAUG | 165.50 | 19.36 | 174.00 | 0.00 | — | — | — | — | 16.70 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 99 | 99 | 90 | |
| 91 | 95 | 76 | |
| Operating Profit | 10 | 6 | 15 |
| OPM % | 10 | 6 | 17 |
| Other Income | 1 | 2 | 2 |
| Interest | 1 | 0 | 0 |
| Depreciation | 3 | 3 | 4 |
| 6 | 3 | 10 | |
| Tax % | 25 | 31 | 28 |
| Net Profit | 5 | 2 | 7 |
| EPS | 5 | 2 | 7 |
| Dividend Payout % | 5 | 0 | 0 |
| Minority Interest | 0 | 0 | -0 |
| Share of Associates | 0 | -0 | -0 |
| Adjusted EPS | 5 | 2 | 7 |
| Minority Interest | 0 | 0 | -0 |
| Share of Associates | 0 | -0 | -0 |
| Adjusted EPS | 5 | 2 | 7 |
Mar 2023
- 99
- 91
- Operating Profit
- 10
- OPM %
- 10
- Other Income
- 1
- Interest
- 1
- Depreciation
- 3
- 6
- Tax %
- 25
- Net Profit
- 5
- EPS
- 5
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 99
- 95
- Operating Profit
- 6
- OPM %
- 6
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 3
- Tax %
- 31
- Net Profit
- 2
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- 2
Mar 2025
- 90
- 76
- Operating Profit
- 15
- OPM %
- 17
- Other Income
- 2
- Interest
- 0
- Depreciation
- 4
- 10
- Tax %
- 28
- Net Profit
- 7
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- -0
- Adjusted EPS
- 7
- Minority Interest
- -0
- Share of Associates
- -0
- Adjusted EPS
- 7
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -15%
- 1 Year:
- 42%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 10%
- Last Year:
- 14%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 11 | 11 | 11 |
| 30 | 32 | 52 | |
| 0 | 2 | 1 | |
| Trade Payables | 9 | 7 | 7 |
| 5 | 19 | 6 | |
| Total Liabilities | 55 | 70 | 77 |
| ASSETS | - | - | - |
| 21 | 28 | 34 | |
| Capital Work in Progress | 2 | 2 | 0 |
| 15 | 18 | 21 | |
| 3 | 4 | 4 | |
| 0 | 6 | 8 | |
| Cash & Bank | 2 | 2 | 2 |
| 12 | 9 | 8 | |
| Total Assets | 55 | 70 | 77 |
| Total Debt | 0 | 2 | 1 |
| Net Working Capital | 15 | 20 | 19 |
| Contingent Liabilities | 1 | 1 | 3 |
| Book Value per Share | 38.48 | 40.10 | 59.44 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 0 | 2 | 1 |
| Net Working Capital | 15 | 20 | 19 |
| Contingent Liabilities | 1 | 1 | 3 |
| Book Value per Share | 38.48 | 40.10 | 59.44 |
| Face Value | 10.00 | 10.00 | 10.00 |
Mar 2023
- Equity Capital
- 11
- 30
- 0
- Trade Payables
- 9
- 5
- Total Liabilities
- 55
- 21
- Capital Work in Progress
- 2
- 15
- 3
- 0
- Cash & Bank
- 2
- 12
- Total Assets
- 55
- Total Debt
- 0
- Net Working Capital
- 15
- Contingent Liabilities
- 1
- Book Value per Share
- 38.48
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 15
- Contingent Liabilities
- 1
- Book Value per Share
- 38.48
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 11
- 32
- 2
- Trade Payables
- 7
- 19
- Total Liabilities
- 70
- 28
- Capital Work in Progress
- 2
- 18
- 4
- 6
- Cash & Bank
- 2
- 9
- Total Assets
- 70
- Total Debt
- 2
- Net Working Capital
- 20
- Contingent Liabilities
- 1
- Book Value per Share
- 40.10
- Face Value
- 10.00
- Total Debt
- 2
- Net Working Capital
- 20
- Contingent Liabilities
- 1
- Book Value per Share
- 40.10
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 11
- 52
- 1
- Trade Payables
- 7
- 6
- Total Liabilities
- 77
- 34
- Capital Work in Progress
- 0
- 21
- 4
- 8
- Cash & Bank
- 2
- 8
- Total Assets
- 77
- Total Debt
- 1
- Net Working Capital
- 19
- Contingent Liabilities
- 3
- Book Value per Share
- 59.44
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 19
- Contingent Liabilities
- 3
- Book Value per Share
- 59.44
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0 | -1 | 11 | |
| Cash from Investing | 1 | -13 | -10 |
| Cash from Financing | -1 | 15 | -1 |
| -1 | 1 | -0 | |
| Free Cash Flow | 0 | -13 | 3 |
| OCF / Net Profit | 0.01 | -0.63 | 1.48 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | 0.01 | -0.63 | 1.48 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- 0
- Cash from Investing
- 1
- Cash from Financing
- -1
- -1
- Free Cash Flow
- 0
- OCF / Net Profit
- 0.01
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.01
- Cumulative 5-Year FCF
- 0
Mar 2024
- -1
- Cash from Investing
- -13
- Cash from Financing
- 15
- 1
- Free Cash Flow
- -13
- OCF / Net Profit
- -0.63
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.63
- Cumulative 5-Year FCF
- 0
Mar 2025
- 11
- Cash from Investing
- -10
- Cash from Financing
- -1
- -0
- Free Cash Flow
- 3
- OCF / Net Profit
- 1.48
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.48
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 4.60 | 1.88 | 6.78 |
| Book Value (₹) | 38.48 | 40.10 | 59.44 |
| Dividend per Share (₹) | 0.25 | 0.00 | 0.00 |
| Cash EPS (₹) | 7.07 | 4.88 | 10.75 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 9.97% | 4.54% | 15.16% |
| Net Margin % | 4.87% | 2.00% | 7.96% |
| ROE % | 11.95% | 4.82% | 13.66% |
| ROCE % | 17.96% | 6.37% | 16.70% |
| 8.82% | 3.20% | 9.78% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 22 | 22 | 28 |
| Inventory Days | 13 | 14 | 16 |
| Payable Days | 118 | 114 | 152 |
| -84 | -78 | -109 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 0.00x | 0.04x | 0.02x |
| Interest Coverage (x) | 8.50x | 12.25x | 44.76x |
| 2.16x | 2.70x | 2.70x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 0.16% | -9.55% |
| Operating Profit Growth % | 0.00% | -36.68% | 147.29% |
| Net Profit Growth % | 0.00% | -58.81% | 259.44% |
| 0.00% | -59.03% | 260.17% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 92.39x | 13.81x |
| P/B (x) | 0.00x | 4.34x | 1.58x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 29.11x | 6.31x |
Mar 2023
- EPS (₹)
- 4.60
- Book Value (₹)
- 38.48
- Dividend per Share (₹)
- 0.25
- Cash EPS (₹)
- 7.07
- Operating Margin %
- 9.97%
- Net Margin %
- 4.87%
- ROE %
- 11.95%
- ROCE %
- 17.96%
- 8.82%
- Debtor Days
- 22
- Inventory Days
- 13
- Payable Days
- 118
- -84
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 8.50x
- 2.16x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 1.88
- Book Value (₹)
- 40.10
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.88
- Operating Margin %
- 4.54%
- Net Margin %
- 2.00%
- ROE %
- 4.82%
- ROCE %
- 6.37%
- 3.20%
- Debtor Days
- 22
- Inventory Days
- 14
- Payable Days
- 114
- -78
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 12.25x
- 2.70x
- Revenue Growth %
- 0.16%
- Operating Profit Growth %
- -36.68%
- Net Profit Growth %
- -58.81%
- -59.03%
- P/E (x)
- 92.39x
- P/B (x)
- 4.34x
- Dividend Yield %
- 0.00%
- 29.11x
Mar 2025
- EPS (₹)
- 6.78
- Book Value (₹)
- 59.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.75
- Operating Margin %
- 15.16%
- Net Margin %
- 7.96%
- ROE %
- 13.66%
- ROCE %
- 16.70%
- 9.78%
- Debtor Days
- 28
- Inventory Days
- 16
- Payable Days
- 152
- -109
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 44.76x
- 2.70x
- Revenue Growth %
- -9.55%
- Operating Profit Growth %
- 147.29%
- Net Profit Growth %
- 259.44%
- 260.17%
- P/E (x)
- 13.81x
- P/B (x)
- 1.58x
- Dividend Yield %
- 0.00%
- 6.31x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
May 2026
Nov 2025
May 2025